Concepedia

P. Cheema

PC

Statistics

Publications

12

Citations

1.1K

H-Index

12

Active since

1985

Affiliations

Dana-Farber Cancer Institute(Current)

Memorial Sloan Kettering Cancer Center

Northwestern University

Wayne State University

University of Wisconsin–Madison

P. Cheema is an author at Dana-Farber Cancer Institute specializing in medicine, pharmacology, and oncology.

Publications per year

1985–2024

12

Publications

12

Immunomodulatory drug costimulates T cells via the B7-CD28 pathway

Richard LeBlanc, Teru Hideshima, Laurence Catley et al. · Blood · 2003 · 286 citations

Life Sciences, Cell Biology, Immunology +14

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102

Noah Kornblum, Fengmin Zhao, Judith Manola et al. · Journal of Clinical Oncology · 2018 · 189 citations · Full text

Medicine, Oncology, Pharmacology +16

Influence of maternal food antigen avoidance during pregnancy and lactation on incidence of atopic eczema in infants

R. K. Chandra, S. Puri, C. SURAIYA et al. · Clinical & Experimental Allergy · 1986 · 180 citations

Life Sciences, Dermatology, Nutrition +13

Predictive value of cord blood IgE in the development of atopic disease and role of breast‐feeding in its prevention

Rakesh K. Chandra, S. Puri, P. Cheema · Clinical & Experimental Allergy · 1985 · 134 citations

Life Sciences, Immunology, Pediatrics +17

SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.

Rachna T. Shroff, Katherine A. Guthrie, Aaron J. Scott et al. · Journal of Clinical Oncology · 2023 · 99 citations

Medicine, Oncology, Pharmacology +9

1–5 of 12